ARMISTICE CAPITAL, LLC

Q2 2024 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
6/30/2024
Date filed
8/14/2024
Form type
13F-HR
Num holdings
254
Total value ($000)
$7,947,900
Net value change ($000)
+407,335 (5.4%)
New positions
77
Sold out positions
156
Turnover %
18.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ALKERMES PLC 46,853 257.5%
Inari Medical, Inc. 37,907 354.7%
SMPL 34,582 NEW
KDP 33,713 211.7%
NVO 26,291 51.2%
PENN 26,080 104.0%
CPB 23,795 97.3%
SCLX 23,064 NEW
IMCR 22,417 210.3%
WDAY 22,372 198.5%
Top Reduces (Value $000, Stocks/ETFs)
Deciphera Pharmaceuticals, Inc. -92,807 -100.0%
KO -35,148 -76.3%
POST -26,796 -100.0%
NOMD -26,436 -100.0%
SYY -25,541 -100.0%
RIGL -22,733 -100.0%
BIIB -21,574 -100.0%
Shockwave Medical, Inc. -21,547 -100.0%
NEVRO CORP -21,413 -40.9%
ARGX -17,934 -17.3%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 4,125,274 (51.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None